Sanofi and Regeneron have celebrated a pair of positive clinical trials in inflammatory skin disorders with blockbuster immunology therapy Dupixent that could both lead to new indications for the ...

Sanofi and Regeneron’s immunology juggernaut Dupixent is on the brink of another big new indication after it was recommended by the EMA’s human medicines committee for chronic obstructive ...

Your trusted source for the latest news delivered weekdays from the team at U.S. News and World Report. Sign in to manage your newsletters » Sign up to receive the latest updates from U.S News ...

This advertisement has not loaded yet, but your article continues below.

Bill Bramhall's editorial cartoon for Friday, Aug. 4, 2023, shows the defense saying, "It's not ...

This advertisement has not loaded yet, but your article continues below.

There’s yet another level to mine.

After the preschool years, kids still like cartoons, but they want something more complex than straightforward messages about friendship and sharing. They like a bit of conflict, some bad guys (who ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...